Search
Search Results
-
Evaluation of pharmacy-led weight management service to minimise the risk of cardiovascular disease
AimsThe primary aim of the programme was a minimum of a 5% weight reduction of the initial weight, while the secondary outcomes were a reduction in...
-
Understand the benefits and risks of intravenous methadone for perioperative and chronic cancer pain management
Intravenous (IV) methadone is a long-acting analgesic opioid with unique properties that may be useful in the management of acute perioperative and...
-
The role of community pharmacists in optimising patient self-management of constipation: an inter-disciplinary consensus view
Constipation is a common gastrointestinal disorder that may occur as occasional (acute) episodes, but can also persist over longer periods of time....
-
Quality Risk Management (QRM)
Risk assessment is a critical process that involves identifying, analyzing, and evaluating potential hazards and risks associated with the drug...
-
Evolving Type 2 diabetes management focuses on clinical outcomes
Type 2 diabetes mellitus, defined by hyperglycaemia, is very common and carries long-term cardiovascular (CV) and renal risks. Management has evolved...
-
Qualification, Continued Process Verification, and Lifecycle Management
Process validation lifecycle qualification and continued process verification (CPV) stages are essential in the manufacturing of pharmaceutical...
-
Knowledge, attitude, and practice of pharmacists regarding asthma management: a cross-sectional study in Egypt
BackgroundAsthma is a significant public health issue that poses a substantial health and economic burden. Despite the availability of effective...
-
Towards intra-articular therapies for more than just symptom management in osteoarthritis
Osteoarthritis is a chronic condition that causes pain and loss of joint function. While currently recommended intra-articular therapies (e.g....
-
Clozapine is the approved option in treatment-resistant schizophrenia and requires careful management
Clozapine is the only agent approved for treatment-resistant schizophrenia, but is underprescribed. Its adverse drug event (ADE) profile and patient...
-
Pharmacological management of psychoactive substance withdrawal syndrome
RationaleMedications are available to manage alcohol and drug withdrawal, but they are underutilized. Only a handful, such as methadone,...
-
Incidence of adverse reaction of drugs used in COVID-19 management: a retrospective, observational study
BackgroundAn urgent need for coronavirus infectious disease (COVID-19) treatment has resulted in off-label drug use. Although previous studies had...
-
Role of clinical pharmacists in epilepsy management at a general hospital in Vietnam: a before-and-after study
BackgroundClinical pharmacists have an important role in inter-professional healthcare collaboration for epilepsy management. However, the pharmacy...
-
Evidence of the Impact of Interventions to Prevent Obesity
Obesity has become a major global health challenge. Urgent global action and strong leadership is needed to help countries more effectively intervene...
-
Dry Biomass and Volatile Oil Production of Achyrocline satureioides Subjected to Agronomic Management Practices
The scarcity of agronomic protocols for the cultivation of Achyrocline satureioides (Lam.) DC., Asteraceae, in Brazil is reflected by the...
-
Structure – Activity Relationship and Therapeutic Benefits of Flavonoids in the Management of Diabetes and Associated Disorders
Commonly flavonoids are the natural components found in vegetables, spices and colored fruits. Flavonoids include a large group of polyphenolic...
-
Revisiting Ipriflavone: a Potential Isoflavone for the Management of Postmenopausal Osteoporosis
Ipriflavone is a nutraceutical extensively used in Asian countries since 1890 for postmenopausal osteoporosis as a phytoestrogen to inhibit bone...
-
Mechanistic correlation of molecular pathways in obesity-mediated stroke pathogenesis
Obesity, a prominent risk factor for the development of heart attacks and several cardiovascular ailments. Obesity ranks as the second most...
-
Setmelanotide in obesity: a profile of its use
Subcutaneous setmelanotide (IMCIVREE ® ), a melanocortin-4 receptor agonist, meets a previously unmet need and thus represents an important advancement...
-
Quinoa and Chia Modulate AMPK/PPAR-ɣ Signaling in High-Fat Diet–Induced Obesity Rat Model
Obesity is one of the principal reasons behind a wide range of metabolic diseases and dramatic health complications. Recent studies shed the light on...
-
Monitor growth changes from central nervous system stimulants in patients with attention-deficit/hyperactivity disorder
CNS stimulants used in the management of attention-deficit/hyperactivity disorder (ADHD) may suppress appetite, and thus growth. In randomised...